Niger vs Syrian Arab Republic: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Niger
3.2%
in 2024
Syrian Arab Republic
2.9%
in 2024
Niger rank
3rd
Syrian Arab Republic rank
1st
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Niger
- Syrian Arab Republic
How they compare
Niger currently reports 3.2% against 2.9% in Syrian Arab Republic, a difference of 0.3%.
That makes Niger's figure about 1.1 times Syrian Arab Republic's.
The two have swapped places 1 time across 10 shared years of data; in 2015 it was Syrian Arab Republic ahead.
Niger ranks 3rd and Syrian Arab Republic ranks 1st of 215 countries.
Across the 2 decades both report, Niger averaged higher in 1 and Syrian Arab Republic in 1.
Head to head by decade
| Decade | Niger | Syrian Arab Republic | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.6% | 3.5% | 0.8% | Syrian Arab Republic |
| 2020s | 3.4% | 3.4% | 0.1% | Niger |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Niger or Syrian Arab Republic?
- Niger, at 3.2% against 2.9% in Syrian Arab Republic as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Niger and Syrian Arab Republic?
- 0.3%, with Niger ahead.
- How many years of comparable data are there for Niger and Syrian Arab Republic?
- 10 years are reported by both, from 2015 to 2024.
- How do Niger and Syrian Arab Republic rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Niger ranks 3rd and Syrian Arab Republic ranks 1st of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.